Avidity Partners Management as of March 31, 2022
Portfolio Holdings for Avidity Partners Management
Avidity Partners Management holds 92 positions in its portfolio as reported in the March 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr Ser Tr S&p Biotech Call Option | 6.2 | $297M | 3.3M | 89.88 | |
| Astrazeneca Sponsored Adr (AZN) | 5.1 | $246M | 3.7M | 66.34 | |
| Abbvie (ABBV) | 4.9 | $238M | 1.5M | 162.11 | |
| Arvinas Ord (ARVN) | 4.1 | $196M | 2.9M | 67.30 | |
| Anthem (ELV) | 4.1 | $196M | 399k | 491.22 | |
| Merck & Co (MRK) | 4.0 | $195M | 2.4M | 82.05 | |
| Avantor (AVTR) | 4.0 | $192M | 5.7M | 33.82 | |
| Baxter International (BAX) | 3.1 | $149M | 1.9M | 77.54 | |
| Zentalis Pharmaceuticals (ZNTL) | 3.1 | $147M | 3.2M | 46.14 | |
| Biohaven Pharmaceutical Holding | 3.0 | $146M | 1.2M | 118.57 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 3.0 | $142M | 546k | 260.97 | |
| UnitedHealth (UNH) | 2.8 | $132M | 260k | 509.97 | |
| United Therapeutics Corporation (UTHR) | 2.7 | $129M | 719k | 179.41 | |
| Horizon Therapeutics Pub L SHS | 2.5 | $119M | 1.1M | 105.21 | |
| Mirati Therapeutics | 2.4 | $115M | 1.4M | 82.22 | |
| Iveric Bio | 2.3 | $109M | 6.5M | 16.83 | |
| Neurocrine Biosciences (NBIX) | 2.3 | $109M | 1.2M | 93.75 | |
| Iovance Biotherapeutics (IOVA) | 2.1 | $101M | 6.0M | 16.65 | |
| Intuitive Surgical Com New (ISRG) | 2.0 | $98M | 325k | 301.68 | |
| Catalent (CTLT) | 1.8 | $87M | 782k | 110.90 | |
| Humana (HUM) | 1.8 | $87M | 199k | 435.17 | |
| Syndax Pharmaceuticals (SNDX) | 1.7 | $84M | 4.8M | 17.38 | |
| Biogen Idec (BIIB) | 1.6 | $77M | 365k | 210.60 | |
| Ultragenyx Pharmaceutical (RARE) | 1.3 | $63M | 869k | 72.62 | |
| Johnson & Johnson (JNJ) | 1.3 | $63M | 354k | 177.23 | |
| Adicet Bio (ACET) | 1.3 | $62M | 3.1M | 19.97 | |
| Kezar Life Sciences (KZR) | 1.2 | $59M | 3.5M | 16.62 | |
| McKesson Corporation (MCK) | 1.2 | $58M | 190k | 306.13 | |
| Argenx Se Sponsored Adr (ARGX) | 1.2 | $56M | 176k | 315.31 | |
| Boston Scientific Corporation (BSX) | 1.1 | $53M | 1.2M | 44.29 | |
| Natera (NTRA) | 1.1 | $53M | 1.3M | 40.68 | |
| Edwards Lifesciences (EW) | 1.1 | $52M | 440k | 117.72 | |
| Arrowhead Pharmaceuticals (ARWR) | 0.9 | $44M | 955k | 45.99 | |
| Immunocore Hldgs Ads (IMCR) | 0.8 | $41M | 1.4M | 29.90 | |
| Legend Biotech Corp Sponsored Ads (LEGN) | 0.8 | $40M | 1.1M | 36.34 | |
| Spdr Ser Tr S&p Biotech (XBI) | 0.8 | $40M | 440k | 89.88 | |
| Bausch Health Companies (BHC) | 0.8 | $39M | 1.7M | 22.85 | |
| Avidity Biosciences Ord (RNA) | 0.8 | $38M | 2.0M | 18.47 | |
| Insmed Com Par $.01 (INSM) | 0.7 | $32M | 1.4M | 23.50 | |
| Alphatec Hldgs Com New (ATEC) | 0.7 | $32M | 2.7M | 11.50 | |
| Ideaya Biosciences (IDYA) | 0.6 | $30M | 2.7M | 11.19 | |
| Chemocentryx | 0.6 | $30M | 1.2M | 25.07 | |
| Axsome Therapeutics (AXSM) | 0.6 | $29M | 711k | 41.39 | |
| Arcus Biosciences Incorporated (RCUS) | 0.6 | $29M | 912k | 31.56 | |
| Intellia Therapeutics (NTLA) | 0.6 | $28M | 390k | 72.67 | |
| Phathom Pharmaceuticals (PHAT) | 0.6 | $27M | 1.9M | 13.61 | |
| Caribou Biosciences (CRBU) | 0.5 | $26M | 2.8M | 9.18 | |
| Nuvation Bio Com Cl A (NUVB) | 0.5 | $26M | 4.9M | 5.26 | |
| Bellus Health Com New | 0.5 | $25M | 3.7M | 6.88 | |
| Seaspine Holdings | 0.5 | $24M | 2.0M | 12.16 | |
| Penumbra (PEN) | 0.5 | $23M | 104k | 222.13 | |
| Si-bone (SIBN) | 0.5 | $23M | 1.0M | 22.60 | |
| Vir Biotechnology (VIR) | 0.4 | $20M | 780k | 25.72 | |
| Miragen Therapeutics (VRDN) | 0.4 | $19M | 1.0M | 18.49 | |
| Blueprint Medicines (BPMC) | 0.4 | $19M | 291k | 63.88 | |
| Altimmune Com New (ALT) | 0.4 | $17M | 2.9M | 6.09 | |
| Essa Pharma Com New (EPIX) | 0.3 | $15M | 2.5M | 6.18 | |
| Seagen | 0.3 | $14M | 100k | 144.05 | |
| Galapagos Nv Spon Adr (GLPG) | 0.3 | $13M | 215k | 62.02 | |
| Century Therapeutics (IPSC) | 0.2 | $11M | 865k | 12.59 | |
| Alpine Immune Sciences (ALPN) | 0.2 | $11M | 1.2M | 8.97 | |
| Apellis Pharmaceuticals (APLS) | 0.2 | $11M | 210k | 50.81 | |
| An2 Therapeutics (ANTX) | 0.2 | $10M | 688k | 15.07 | |
| Erasca (ERAS) | 0.2 | $8.6M | 995k | 8.60 | |
| Sentinelone Cl A (S) | 0.2 | $7.9M | 205k | 38.74 | |
| Cyteir Therapeutics | 0.1 | $7.0M | 1.9M | 3.77 | |
| Phasebio Pharmaceuticals (PHASQ) | 0.1 | $5.8M | 4.4M | 1.32 | |
| Caremax Com Cl A | 0.1 | $5.6M | 755k | 7.47 | |
| Tango Therapeutics (TNGX) | 0.1 | $5.5M | 721k | 7.58 | |
| Hyperfine Com Cl A (HYPR) | 0.1 | $5.3M | 1.5M | 3.54 | |
| Medicus Sciences Acquisition Cl A Shs | 0.1 | $5.1M | 520k | 9.78 | |
| Bcls Acquisition Corp Com Cl A | 0.1 | $4.9M | 500k | 9.87 | |
| Dynamics Special Purpose Cor Class A Com | 0.1 | $4.9M | 500k | 9.87 | |
| Arya Sciences Acqu Corp Iv Cl A (ARYD) | 0.1 | $4.9M | 500k | 9.80 | |
| Panacea Acquisition Corp Ii Cl A Shs | 0.1 | $4.9M | 500k | 9.75 | |
| Helix Acquisition Corp Com Cl A | 0.1 | $4.4M | 400k | 11.10 | |
| Field Trip Health Ord | 0.1 | $4.0M | 3.0M | 1.34 | |
| Health Sciences Acq Corp 2 Ord Shs | 0.1 | $4.0M | 400k | 9.91 | |
| Graphite Bio | 0.1 | $3.6M | 710k | 5.10 | |
| Oncosec Medical Incorporated | 0.1 | $3.4M | 2.9M | 1.15 | |
| Otonomy | 0.1 | $3.2M | 1.3M | 2.40 | |
| Sema4 Holdings Corp Com Cl A | 0.1 | $2.9M | 950k | 3.07 | |
| Compass Therapeutics (CMPX) | 0.1 | $2.7M | 2.0M | 1.37 | |
| Gritstone Oncology Ord (GRTS) | 0.0 | $2.3M | 560k | 4.12 | |
| Science 37 Holdings | 0.0 | $2.3M | 430k | 5.35 | |
| Scynexis Com New (SCYX) | 0.0 | $2.1M | 544k | 3.91 | |
| Social Cap Suvretta Hld Crpi Class A Ord Shs | 0.0 | $2.0M | 200k | 9.90 | |
| Social Cap Suvretta Hlds Crp Class A Ord Shs | 0.0 | $2.0M | 200k | 9.89 | |
| Social Cap Suvretta Hlds Crp Class A Ord Shs | 0.0 | $2.0M | 200k | 9.75 | |
| Social Cap Suvretta Hlds Cp Class A Ord Shs | 0.0 | $1.9M | 200k | 9.74 | |
| Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.0 | $76k | 100k | 0.76 | |
| Medicus Sciences Acquisition *w Exp 02/12/202 | 0.0 | $25k | 58k | 0.43 |
